These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 32038663)
1. Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients. Pilon C; Bigot J; Grondin C; Thiolat A; Lang P; Cohen JL; Grimbert P; Matignon M Front Immunol; 2020; 11():34. PubMed ID: 32038663 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J Clin Transpl; 2014; ():223-30. PubMed ID: 26281149 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study. Matignon M; Pilon C; Commereuc M; Grondin C; Leibler C; Kofman T; Audard V; Cohen J; Canoui-Poitrine F; Grimbert P PLoS One; 2017; 12(6):e0178572. PubMed ID: 28654684 [TBL] [Abstract][Full Text] [Related]
4. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R Clin Transpl; 2014; ():215-21. PubMed ID: 26281148 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial. Moreso F; Crespo M; Ruiz JC; Torres A; Gutierrez-Dalmau A; Osuna A; Perelló M; Pascual J; Torres IB; Redondo-Pachón D; Rodrigo E; Lopez-Hoyos M; Seron D Am J Transplant; 2018 Apr; 18(4):927-935. PubMed ID: 28949089 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531 [TBL] [Abstract][Full Text] [Related]
7. High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts. Alfonso J; Gralla J; Klem P; Chan L; Wiseman AC; Cooper JE Clin Transpl; 2014; ():161-70. PubMed ID: 26281141 [TBL] [Abstract][Full Text] [Related]
8. High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction. Cooper JE; Gralla J; Klem P; Chan L; Wiseman AC Transplantation; 2014 Jun; 97(12):1253-9. PubMed ID: 24937199 [TBL] [Abstract][Full Text] [Related]
9. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854 [TBL] [Abstract][Full Text] [Related]
10. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion. Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916 [TBL] [Abstract][Full Text] [Related]